HSPD1 and metabolic dysfunction-associated steatotic liver disease: There was upregulation in the expression of HSPD1 mRNA by 1.3-fold in NAFLD cases compared to healthy controls, 3.5-fold in simple steatosis cases compared to NAFLD cases and 2-fold in NASH cases compared to simple steatosis cases.